- Acadia Pharma (ACAD) is scheduled to announce Q3 earnings results on Wednesday, November 5th, after market close.
- The consensus EPS Estimate is $0.15 and the consensus revenue estimate is $276.54M (+10.4% Y/Y).
- Over the last 3 months, EPS estimates have seen 8 upward revisions and 4 downward. Revenue estimates have seen 14 upward revisions and 2 downward.
Acadia Pharma Q3 2025 Earnings Preview
